Minireview: Parabens Exposure and Breast Cancer
Open accessThe DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
There is increasing recognition that environmental exposure to chemicals, such as endocrine-disruptive chemicals (EDCs), contributes to the development of breast cancer. Parabens are a group of EDCs commonly found in personal care products, foods, and pharmaceuticals. Systemic exposure to parabens has been confirmed by the ubiquitous detection of parabens in human blood and urine samples. Although evidence from in vivo and epidemiological studies linking parabens exposure to breast cancer is limited, the current evidence suggests that parabens may negatively interfere with some endocrine and intracrine targets relevant to breast carcinogenesis. So far, most studies have focused on a single paraben's effects and the direct modulating effects on estrogen receptors or the androgen receptor in vitro. Recent studies have revealed that parabens can modulate local estrogen-converting enzymes, 17β-hydroxysteroid dehydrogenase 1 and 2 and increase local estrogen levels. Also, parabens can crosstalk with the human epidermal growth factor receptor 2 (HER2) pathway and work with ER signaling to increase pro-oncogenic c-Myc expression in ER+/HER2+ breast cancer cells. Future studies investigating paraben mixtures and their crosstalk with other EDCs or signaling pathways both in vitro and in vivo in the context of breast cancer development are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recently, in 2014, the European Union amended its laws and regulations and further lowered the concentration of parabens in cosmetics and baby products, for example, Regulation No. 1004/2014 has now further reduced the permitted concentration of certain parabens, including propylparaben (i.e., a propyl ester of phenol p-hydroxybenzoic acid) and butylparaben (i.e., a butyl ester of phenol p-hydroxy”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Estrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,862
Iqbal, N., & Iqbal, N. (2014) · Molecular Biology International · doi:10.1155/2014/852748 · Cited by 1,381
La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., Guyton, K. Z., Kortenkamp, A., Cogliano, V. J., Woodruff, T. J., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0273-8 · Cited by 1,005
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Concentrations of parabens in human breast tumours
Darbre, P. D., Aljarrah, A., Miller, W. R., Coldham, N. G., Sauer, M. J., & Pope, G. S. (2004) · Journal of Applied Toxicology · doi:10.1002/jat.958 · Cited by 805 · cited 3×
“On the other hand, isobutyl (IsoBP), isopropyl (IsoPP), and benzyl (BzP) parabens are less commonly used in household products [18,19].”
BackgroundOncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
Self-citationDarbre, P. D., & Harvey, P. W. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1358 · Cited by 697
Doane, A. S., Danso, M., Lal, P., Donaton, M., Zhang, L., Hudis, C., & Gerald, W. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209415 · Cited by 603
Parabens and their effects on the endocrine system
Nowak, K., Ratajczak–Wrona, W., Górska, M., & Jabłońska, E. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.03.014 · Cited by 472
Urinary Concentrations of Four Parabens in the U.S. Population: NHANES 2005–2006
Calafat, A. M., Ye, X., Wong, L.-Y., Bishop, A. M., & Needham, L. L. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901560 · Cited by 451
Rodgers, K. M., Udesky, J. O., Rudel, R. A., & Brody, J. G. (2018) · Environmental Research · doi:10.1016/j.envres.2017.08.045 · Cited by 443
A Review of the Endocrine Activity of Parabens and Implications for Potential Risks to Human Health
Golden, R., Gandy, J., & Vollmer, G. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440490920104 · Cited by 416
Prevalence of Mammographically Dense Breasts in the United States
Sprague, B. L., Gangnon, R. E., Burt, V., Trentham-Dietz, A., Hampton, J. M., Wellman, R. D., Kerlikowske, K., & Miglioretti, D. L. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju255 · Cited by 400
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Shirley Liu, X., & Brown, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 397
Harada, N., Utsumi, T., & Takagi, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11312 · Cited by 361
Development of the human breast
Russo, J., & Russo, I. H. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.04.011 · Cited by 324
Parabens as Urinary Biomarkers of Exposure in Humans
Ye, X., Bishop, A. M., Reidy, J. A., Needham, L. L., & Calafat, A. M. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9413 · Cited by 312
Chen, J., Ahn, K. C., Gee, N. A., Gee, S. J., Hammock, B. D., & Lasley, B. L. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.015 · Cited by 253
Self-citationTissue physiology and pathology of aromatase
Stocco, C. (2012) · Steroids · doi:10.1016/j.steroids.2011.10.013 · Cited by 246
Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model
Vo, T. T. B., Yoo, Y.-M., Choi, K.-C., & Jeung, E.-B. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.01.013 · Cited by 245
Wang, L., Asimakopoulos, A. G., & Kannan, K. (2015) · Environment International · doi:10.1016/j.envint.2015.02.015 · Cited by 234
Lee, H.-R., Kim, T.-H., & Choi, K.-C. (2012) · Laboratory Animal Research · doi:10.5625/lar.2012.28.2.71 · Cited by 228
Environmental oestrogens, cosmetics and breast cancer
Darbre, P. D. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.09.007 · Cited by 227
Key stages in mammary gland development: The mammary end bud as a motile organ
Hinck, L., & Silberstein, G. B. (2005) · Breast Cancer Research · doi:10.1186/bcr1331 · Cited by 222
Barr, L., Metaxas, G., Harbach, C. A. J., Savoy, L. A., & Darbre, P. D. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.1786 · Cited by 216
Aromatase expression and regulation in breast and endometrial cancer
Zhao, H., Zhou, L., Shangguan, A. J., & Bulun, S. E. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0310 · Cited by 216
Development of the Human Breast
Lteif, A., & Javed, A. (2013) · Seminars in Plastic Surgery · doi:10.1055/s-0033-1343989 · Cited by 215
Harley, K. G., Berger, K. P., Kogut, K., Parra, K., Lustig, R. H., Greenspan, L. C., Calafat, A. M., Ye, X., & Eskenazi, B. (2019) · Human Reproduction · doi:10.1093/humrep/dey337 · Cited by 211
Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies
Wan, M. L. Y., Co, V. A., & El-Nezami, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1903382 · Cited by 208
Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay.
Miller, D., Wheals, B. B., Beresford, N., & Sumpter, J. P. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.109-1240632 · Cited by 206
The Androgen Receptor in Breast Cancer
Giovannelli, P., Di Donato, M., Galasso, G., Di Zazzo, E., Bilancio, A., & Migliaccio, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00492 · Cited by 204
Effects of Parabens on Adipocyte Differentiation
Hu, P., Chen, X., Whitener, R. J., Boder, E. T., Jones, J. O., Porollo, A., Chen, J., & Zhao, L. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs262 · Cited by 198
Self-citationKarwacka, A., Zamkowska, D., Radwan, M., & Jurewicz, J. (2019) · Human Fertility · doi:10.1080/14647273.2017.1358828 · Cited by 188
Pugazhendhi, D., Pope, G. S., & Darbre, P. D. (2005) · Journal of Applied Toxicology · doi:10.1002/jat.1066 · Cited by 172
Oestrogenic activity of isobutylparaben in vitro and in vivo
Darbre, P. D., Byford, J. R., Shaw, L. E., Horton, R. A., Pope, G. S., & Sauer, M. J. (2002) · Journal of Applied Toxicology · doi:10.1002/jat.860 · Cited by 170
Drasin, D. J., Robin, T. P., & Ford, H. L. (2011) · Breast Cancer Research · doi:10.1186/bcr3037 · Cited by 168
Darbre, P. D., & Harvey, P. W. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3027 · Cited by 165
Overview of the relevance of PI3K pathway in HR-positive breast cancer
Vasan, N., Toska, E., & Scaltriti, M. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz281 · Cited by 164
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Fedele, M., Cerchia, L., & Chiappetta, G. (2017) · Cancers · doi:10.3390/cancers9100134 · Cited by 163
Pelch, K. E., Li, Y., Perera, L., Thayer, K. A., & Korach, K. S. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz173 · Cited by 161
Form and Function: how Estrogen and Progesterone Regulate the Mammary Epithelial Hierarchy
Arendt, L. M., & Kuperwasser, C. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9337-0 · Cited by 159
Oestrogenic activity of benzylparaben
Darbre, P. D., Byford, J. R., Shaw, L. E., Hall, S., Coldham, N. G., Pope, G. S., & Sauer, M. J. (2003) · Journal of Applied Toxicology · doi:10.1002/jat.886 · Cited by 158
Harvey, P. W., & Darbre, P. (2004) · Journal of Applied Toxicology · doi:10.1002/jat.978 · Cited by 157
Wang, L., Wu, Y., Zhang, W., & Kannan, K. (2013) · Environmental Science & Technology · doi:10.1021/es304659r · Cited by 144
In vivo and in vitro estrogen bioactivities of alkyl parabens
Lemini, C., Jaimez, R., Ávila, M. E., Franco, Y., Larrea, F., & Lemus, A. E. (2003) · Toxicology and Industrial Health · doi:10.1191/0748233703th177oa · Cited by 136
Kang, H.-S., Kyung, M.-S., Ko, A., Park, J., Hwang, M.-S., Kwon, J.-E., Suh, J.-H., Lee, H., Moon, G. I., Hong, J.-H., et al. (2016) · Environmental Research · doi:10.1016/j.envres.2015.12.032 · Cited by 135
Sandanger, T. M., Huber, S., Moe, M. K., Braathen, T., Leknes, H., & Lund, E. (2011) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2011.22 · Cited by 126
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells
Treeck, O., Lattrich, C., Springwald, A., & Ortmann, O. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0413-2 · Cited by 124
Gunnarsson, C., Olsson, B., & Stål, O. (2001) · PubMed · Cited by 123
Terasaka, S., Inoue, A., Tanji, M., & Kiyama, R. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.10.005 · Cited by 122
Circulating serum xenoestrogens and mammographic breast density
Sprague, B. L., Trentham‐Dietz, A., Hedman, C. J., Wang, J., Hemming, J. D. C., Hampton, J. M., Buist, D. S. M., Bowles, E. J. A., Sisney, G. S., & Burnside, E. S. (2013) · Breast Cancer Research · doi:10.1186/bcr3432 · Cited by 120
Hilborn, E., Stål, O., & Jansson, A. (2017) · Oncotarget · doi:10.18632/oncotarget.15547 · Cited by 119
Liao, Y., Xia, X., Liu, N., Cai, J., Guo, Z., Li, Y., Jiang, L., Dou, Q. P., Tang, D., Huang, H., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0069-z · Cited by 118
Giovannelli, P., Donato, M. D., Auricchio, F., Castoria, G., & Migliaccio, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41016-4 · Cited by 114
GPER–novel membrane oestrogen receptor
Zimmerman, M. A., Budish, R. A., Kashyap, S., & Lindsey, S. H. (2016) · Clinical Science · doi:10.1042/cs20160114 · Cited by 113
Parabens: Potential impact of Low-Affinity Estrogen receptor Binding chemicals on Human health
Karpuzoglu, E., Holladay, S. D., & Gogal, R. M. (2013) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2013.809252 · Cited by 112
G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
Xu, S., Yu, S., Dong, D., & Lee, L. T. O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00725 · Cited by 107
Serum testosterone levels and breast cancer recurrence
Berrino, F., Pasanisi, P., Bellati, C., Venturelli, E., Krogh, V., Mastroianni, A., Berselli, E., Muti, P. C., & Secreto, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20582 · Cited by 102
G-Protein Coupled Estrogen Receptor in Breast Cancer
Hsu, L.-H., Chu, N.-M., Lin, Y.-F., & Kao, S.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020306 · Cited by 102
van Meeuwen, J. A., Son, O.-L., Piersma, A. H., de Jong, P. C., & van den Berg, M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.002 · Cited by 101
the Southeast Sweden Breast Cancer Group, Gunnarsson, C., Hellqvist, E., & Stål, O. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602375 · Cited by 97
Parada, H., Gammon, M. D., Ettore, H. L., Chen, J., Calafat, A. M., Neugut, A. I., Santella, R. M., Wolff, M. S., & Teitelbaum, S. L. (2019) · Environment International · doi:10.1016/j.envint.2019.05.084 · Cited by 94
Self-citationKhanna, S., Dash, P. R., & Darbre, P. D. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3003 · Cited by 92
Engeli, R. T., Rohrer, S. R., Vuorinen, A., Herdlinger, S., Kaserer, T., Leugger, S., Schuster, D., & Odermatt, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18092007 · Cited by 89
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Girgert, R., Emons, G., & Gründker, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00781 · Cited by 89
Tumour-stromal interactions. Role of the stroma in mammary development.
Silberstein, G. B. (2001) · Breast Cancer Research · doi:10.1186/bcr299 · Cited by 87
Freire, C., Molina-Molina, J.-M., Iribarne-Durán, L. M., Jiménez-Díaz, I., Vela-Soria, F., Mustieles, V., Arrebola, J. P., Fernández, M. F., Artacho‐Cordón, F., & Olea, N. (2019) · Environment International · doi:10.1016/j.envint.2019.04.013 · Cited by 87
Sasano, H., Miki, Y., Nagasaki, S., & Suzuki, T. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02444.x · Cited by 86
Progression and treatment of HER2-positive breast cancer
Davoli, A., Hocevar, B. A., & Brown, T. L. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1208-1 · Cited by 85
Wróbel, A. M., & Gregoraszczuk, E. Ł. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71024-7 · Cited by 70
Kunc, M., Biernat, W., & Senkus, E. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.05.005 · Cited by 70
Wróbel, A. M., & Gregoraszczuk, E. Ł. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.08.012 · Cited by 68
Kolšek, K., Gobec, M., Mlinarič‐Raščan, I., & Dolenc, M. S. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.08.009 · Cited by 68
Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells
Pan, S., Yuan, C., Tagmount, A., Rudel, R. A., Ackerman, J. M., Yaswen, P., Vulpe, C. D., & Leitman, D. C. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1409200 · Cited by 68
Sun, L., Yu, T., Guo, J., Zhang, Z., Hu, Y., Xiao, X., Sun, Y., Xiao, H., Li, J., Zhu, D., et al. (2016) · Scientific Reports · doi:10.1038/srep25173 · Cited by 68
Lanari, C., & Molinolo, A. (2002) · Breast Cancer Research · doi:10.1186/bcr539 · Cited by 67
The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells
Yan, Y., Liu, H., Wen, H., Jiang, X., Cao, X., Zhang, G., & Liu, G. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1579-9 · Cited by 63
Pugazhendhi, D., Sadler, A. J., & Darbre, P. D. (2007) · Journal of Applied Toxicology · doi:10.1002/jat.1200 · Cited by 62
Khanna, S., & Darbre, P. D. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2753 · Cited by 59
Marchese, S. D., & Silva, E. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045767 · Cited by 56
Association between healthy lifestyle score and breast cancer
Ghosn, B., Benisi-Kohansal, S., Ebrahimpour‐Koujan, S., Azadbakht, L., & Esmaillzadeh, A. (2020) · Nutrition Journal · doi:10.1186/s12937-020-0520-9 · Cited by 55
Guan, B., Yan, R., Huang, J., Li, F.-L., Zhong, Y.-X., Chen, Y., Liu, F., Hu, B., Huang, S.-B., & Yin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.990781 · Cited by 53
Methylparaben stimulates tumor initiating cells in ER+ breast cancer models
Lillo, M. A., Nichols, C., Perry, C., Runke, S., Krutilina, R., Seagroves, T. N., Miranda‐Carboni, G. A., & Krum, S. A. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3374 · Cited by 53
Wróbel, A. M., & Gregoraszczuk, E. Ł. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.08.001 · Cited by 51
Prenatal exposure to bisphenols and parabens and impacts on human physiology.
Kolátorová, L., Dušková, M., Vítků, J., & Stárka, Ľ. (2017) · Physiological Research · doi:10.33549/physiolres.933723 · Cited by 51
Wu, A. H., Franke, A. A., Wilkens, L. R., Tseng, C.-C., Conroy, S. M., Li, Y., Sangaramoorthy, M., Polfus, L. M., DeRouen, M. C., Caberto, C., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33692 · Cited by 46
Estrogen receptor subtypes dictate the proliferative nature of the mammary gland
Dall, G., Hawthorne, S. C. J., Seyed‐Razavi, Y., Vieusseux, J. L., Wu, W., Gustafsson, J.-Α., Byrne, D. J., Murphy, L. C., Risbridger, G. P., & Britt, K. L. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0582 · Cited by 44
Savci-Heijink, C. D., Halfwerk, H., Hooijer, G. K. J., Köster, J., Horlings, H. M., Meijer, S. L., & van de Vijver, M. J. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05089-5 · Cited by 44
Role of G Protein-Coupled Estrogen Receptor in Cancer Progression
Jung, J. (2019) · Toxicological Research · doi:10.5487/tr.2019.35.3.209 · Cited by 44
Endocrine disrupting chemicals and breast cancer cells
Darbre, P. D. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.04.006 · Cited by 42
Gopalakrishnan, K., Teitelbaum, S. L., Lambertini, L., Wetmur, J. G., Manservisi, F., Falcioni, L., Panzacchi, S., Belpoggi, F., & Chen, J. (2016) · Environmental Research · doi:10.1016/j.envres.2016.10.021 · Cited by 41
Self-citationWróbel, A. M., & Gregoraszczuk, E. Ł. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.2978 · Cited by 37
Yazawa, T., Imamichi, Y., Uwada, J., Sekiguchi, T., Mikami, D., Kitano, T., Ida, T., Sato, T., Nemoto, T., Nagata, S., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105493 · Cited by 33
Shen, X., Liang, J., Zheng, L., Lv, Q., & Wang, H. (2017) · Journal of Separation Science · doi:10.1002/jssc.201700722 · Cited by 31
Paraben concentrations in human fingernail and its association with personal care product use
Li, C., Cui, X., Chen, Y., & Liao, C. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110933 · Cited by 30
Estrogenic activity of constituents of underarm deodorants determined by E-Screen assay
Lange, C., Kuch, B., & Metzger, J. W. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.02.082 · Cited by 25
Venturelli, E., Orenti, A., Fabricio, A. S. C., Garrone, G., Agresti, R., Paolini, B., Bonini, C., Gion, M., Berrino, F., Desmedt, C., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4558-4 · Cited by 22
Underarm cosmetics and breast cancer
Darbre, P. D. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200404000-00013 · Cited by 19
Zhou, H.-T., Chen, H., & Ding, W.-H. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.12.038 · Cited by 17
Perian, S., Cerutti, C., Forcet, C., Tribollet, V., & Vanacker, J.-M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00547 · Cited by 7
Research works printed but not linked: 1
- Satoh, 2005, Androgenic and Antiandrogenic Effects ofAlkylphenols and Parabens AssessedUsing the Reporter Gene Assay withStably Transfected CHO-K1 Cells(AR-EcoScreen System), J. Health Sci., 51, 12
Cited by
The adverse role of endocrine disrupting chemicals in the reproductive system
Pan, J., Liu, P., Yu, X., Zhang, Z., & Liu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1324993 · Cited by 176
Women, power, and cancer: a Lancet Commission
Ginsburg, O., Vanderpuye, V., Beddoe, A. M., Bhoo-Pathy, N., Bray, F., Caduff, C., Florez, N., Fadhil, I., Hammad, N., Heidari, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01701-4 · Cited by 163
Milk-Derived Antimicrobial Peptides: Overview, Applications, and Future Perspectives
Singh, A., Duche, R. T., Wandhare, A. G., Kaur, J., Singh, B. P., Sihag, M. K., Singh, K. S., Sangwan, V., Talan, S., & Panwar, H. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-10004-y · Cited by 95
Alnuqaydan, A. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439027 · Cited by 84
“…in cosmetics and baby products, for example, Regulation No. 1004/2014 has now further reduced the permitted concentration of certain parabens, including propylparaben (i.e., a propyl ester of phenol p-hydroxybenzoic acid) and butylparaben (i.e., a butyl ester of phenol p-hydroxybenzoic acid) (70).”
BackgroundTFOS Lifestyle: Impact of cosmetics on the ocular surface
Sullivan, D. A., da Costa, A. X., DUCA, E. D., Doll, T., Grupcheva, C. N., Lazreg, S., Liu, S., McGee, S. R., Murthy, R., Narang, P., et al. (2023) · The Ocular Surface · doi:10.1016/j.jtos.2023.04.005 · Cited by 81
Metadata
- Authors
- Hager, E., Chen, J., & Zhao, L.
- Affiliations
- University of Tennessee at Knoxville (US)
- Corresponding author
- Chen, Jiangang
- Zhao, Ling
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2022-02-08
- Volume
- 19
- Issue
- 3
- Pages
- 1873
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC8834979
- OpenAlex
- W4211192595
- Cited by
- 110
- References
- 102
- Citations by year
- 2026: 17 · 2025: 33 · 2024: 29 · 2023: 21 · 2022: 10
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (1R15DK114790-01A1)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- parabens, breast cancer, endocrine disruptors, environmental exposure, estrogen receptor, androgen receptor, 17β-hydroxysteroid dehydrogenase, c-Myc, personal care products, mammary carcinogenesis, chemical mixtures
- MeSH terms
- Breast Neoplasms, Cosmetics, Environmental Exposure, Estrogens, Female, Humans, Parabens, Receptors, Estrogen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
